The 9th Project and Portfolio Management for Pharma & Biotech East or West – Learn from the best

by Fleming. Team

In a time when pharma R&D costs are increasing and mergers & acquisitions are at an all-time high, the industry needs to consider its next steps.

Learn both practice and the art of research plus summarize the latest insights from both industry professionals and strategic decision makers. Portfolio management can be whatever senior management makes of it. It involves a broad mix containing everything from strategic management, decision making, risk evaluation and innovative thinking through different portfolio and product strategies to navigating between regulatory issues and market demands.

Do you want to learn:

· How disruptive projects are different?

· Why to launch them and how to manage them?

· How to achieve rewards?

· How to manage risk at the portfolio level?

· How to balance costs and new drug approvals?

· How to innovate in R&D?

Join The 9th Project and Portfolio Management for Pharma and Biotech – East, 9th - 10th March 2016, in Philadelphia. Are you busy during these dates or do you live closer to the west coast area?

Then join The 9th Project and Portfolio Management for Pharma and Biotech – West, held 11th - 12th April 2016 in San Francisco.

Bringing together senior executives from pharma and biotech, these events seek to explore new advancements in portfolio management. Professionals from companies such as Eli Lilly and Company, Johnson & Johnson Innovation, Pfizer, AstraZeneca, Novartis and Allergan are on board.

How will you learn?

· CEO roundtable

· Interactive platform

· Point-of-View session hosted by industry leaders

· Real-world case studies

· Practical exercises

Over 10 hours of knowledge sharing and 8 hours of networking over coffee, lunch and cocktails make these events not to be missed.

Interested in this topic?

More articles